Patients with high viral load at switch are at high risk of early failure and may deserve special strategies: to note that both clinical trials testing combinations with raltegravir [ 4 , 5 ] showed a trend towards a better response in patients with high viral load using raltegravir than NRTI in combination with bPI.
← all excerpts
Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa.
1
—
—